Avricore Health Inc. (8VP1.F)
- Previous Close
0.0295 - Open
0.0265 - Bid 0.0260 x --
- Ask 0.0415 x --
- Day's Range
0.0265 - 0.0265 - 52 Week Range
0.0150 - 0.2020 - Volume
10,000 - Avg. Volume
172 - Market Cap (intraday)
2.934M - Beta (5Y Monthly) --
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
avricore.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 8VP1.F
View MorePerformance Overview: 8VP1.F
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8VP1.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8VP1.F
View MoreValuation Measures
Market Cap
3.27M
Enterprise Value
3.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
1.86
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
8.42
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.98%
Return on Assets (ttm)
4.62%
Return on Equity (ttm)
-33.65%
Revenue (ttm)
4.79M
Net Income Avi to Common (ttm)
-668.98k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
785.87k